Clinical evolution of Kearns-Sayre syndrome with polyendocrinopathy and respiratory failure

Acta Neurologica Scandinavica

Volumn 115, Issue SUPPL.187, 2007, Pages 64-67

  Sanaker, P S ^a,b   Husebye, E S ^a,b   Fondenes, O ^b   Bindoff, L A ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Endocrine disease; Kearns Sayre syndrome; Mitochondrial disease; Respiratory failure

Indexed keywords

CORTISONE; ENZYME ANTIBODY; FLUDROCORTISONE; INSULIN; STEROID 21 MONOOXYGENASE; THYROID PEROXIDASE ANTIBODY; THYROXINE; AUTOANTIBODY; HLA ANTIGEN;

ACUTE RESPIRATORY FAILURE; ADDISON DISEASE; ADRENAL INSUFFICIENCY; ADULT; ANTIBODY DETECTION; APNEA; ARTIFICIAL VENTILATION; AUTOIMMUNE THYROIDITIS; CASE REPORT; COMORBIDITY; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DISEASE COURSE; ENDOCRINE DISEASE; EVOLUTION; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE INTOLERANCE; HORMONE SUBSTITUTION; HOSPITAL INFECTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCAPNIA; HYPERGLYCEMIA; HYPERKALEMIA; HYPONATREMIA; HYPOTHYROIDISM; HYPOXEMIA; INSULIN TREATMENT; INVASIVE PROCEDURE; KEARNS SAYRE SYNDROME; NON INVASIVE PROCEDURE; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; SEPTICEMIA; TREATMENT OUTCOME; ADRENAL CORTEX; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY; CENTRAL SLEEP APNEA SYNDROME; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENETICS; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; RESPIRATORY FAILURE; THYROID GLAND;

ADDISON DISEASE; ADRENAL CORTEX; ADULT; AUTOANTIBODIES; FEMALE; HLA ANTIGENS; HUMANS; HYPERGLYCEMIA; HYPOTHYROIDISM; KEARNS-SAYER SYNDROME; MITOCHONDRIAL DISEASES; POLYENDOCRINOPATHIES, AUTOIMMUNE; RESPIRATORY INSUFFICIENCY; SLEEP APNEA, CENTRAL; THYROID GLAND;

EID: 34047219863     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00850.x     Document Type: Conference Paper

References (22)

1. KEARNS TP, SAYRE GP. Retinitis pigmentosa, external ophthalmophlegia, and complete heart block: unusual syndrome with histologic study in one of two cases. AMA Arch Ophthalmol 1958;60:280-9.
2. SCHONER J. Oxidative phosphorylation diseases. In: Scriver CR SW, Valle D eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995;1535-629.
3. SIMON DK, JOHNS DR. Mitochondrial disorders: clinical and genetic features. Annu Rev Med 1999;50:111-27.
4. CHINNERY PF, DIMAURO S, SHANSKE S, et al. Risk of developing a mitochondrial DNA deletion disorder. Lancet 2004;364:592-6.
5. HARVEY JN, BARNETT D. Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol (Oxf) 1992;37:97-103.
6. BOLES RG, ROE T, SENADHEERA D, MAHNOVSKI V, WONG LJ. Mitochondrial DNA deletion with Kearns Sayre syndrome in a child with Addison disease. Eur J Pediatr 1998;157:643-7.
7. OHNO K, YAMAMOTO M, ENGEL AG, et al. MELAS- and Kearns-Sayre-type co-mutation [corrected] with myopathy and autoimmune polyendocrinopathy. Ann Neurol 1996;39:761-6.
8. BERIO A, PIAZZI A. A case of Kearns-Sayre syndrome with autoimmune thyroiditis and possible Hashimoto encephalopathy. Panminerva Med 2002;44:265-9.
9. KOBAYASHI T, OKA Y, KATAGIRI H, et al. Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243. Diabetologia 1996;39:1196- 200.
10. ARTUCH R, PAVIA C, PLAYAN A, et al. Multiple endocrine involvement in two pediatric patients with Kearns-Sayre syndrome. Horm Res 1998;50:99-104.
11. SUZUKI S, HINOKIO Y, HIRAI S, et al. Pancreatic beta-cell secretory defect associated with mitochondrial point mutation of the tRNA (LEU(UUR)) gene: a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS). Diabetologia 1994;37:818-25.
12. DE ANDRADE PB, RUBI B, FRIGERIO F, VAN DEN OUWELAND JM, MAASSEN JA, MAECHLER P. Diabetes-associated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for beta cell function. Diabetologia 2006;49:1816-26.
13. VAIDYA B, PEARCE S, KENDALL-TAYLOR P. Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure. Clin Endocrinol (Oxf) 2000;53:403-18.
14. TANDON N, ZHANG L, WEETMAN AP. HLA associations with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1991;34:383-6.
15. ISOTANI H, FUKUMOTO Y, KAWAMURA H, et al. Hypoparathyroidism and insulin-dependent diabetes mellitus in a patient with Kearns-Sayre syndrome harbouring a mitochondrial DNA deletion. Clin Endocrinol (Oxf) 1996;45:637-41.
16. OKA Y, KATAGIRI H, YAZAKI Y, MURASE T, KOBAYASHI T. Mitochondrial gene mutation in islet-cell-antibody- positive patients who were initially non-insulin-dependent diabetics. Lancet 1993;342:527-8.
17. WENG TR, SCHULTZ GE, CHANG CH, NIGRO MA. Pulmonary function and ventilatory response to chemical stimuli in familial myopathy. Chest 1985;88:488-95.
18. TATSUMI C, TAKAHASHI M, YORIFUJI S, et al. Mitochondrial encephalomyopathy with sleep apnea. Eur Neurol 1988;28:64-9.
19. CUMMISKEY J, GUILLEMINAULT C, DAVIS R, DUNCAN K, GOLDEN J. Automatic respiratory failure: sleep studies and Leigh's disease (case report). Neurology 1987;37:1876-8.
20. BAROHN RJ, CLANTON T, SAHENK Z, MENDELL JR. Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies. Neurology 1990;40:103-6.
21. CARROLL JE, ZWILLICH C, WEIL JV, BROOKE MH. Depressed ventilatory response in oculocraniosomatic neuromuscular disease. Neurology 1976;26:140-6.
22. OSANAI S, TAKAHASHI T, ENOMOTO H, et al. Hypoxic ventilatory depression in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. Respirology 2001;6:163-6.